Literature DB >> 14977924

Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production.

Nilufer B Norsworthy1, Jiaren Sun, Dia Elnaiem, Gregory Lanzaro, Lynn Soong.   

Abstract

After transmission through the bite of female sand flies, Leishmania spp. can cause a broad spectrum of disease manifestations collectively known as leishmaniases. L. amazonensis is endemic in South America, where it causes cutaneous, diffuse cutaneous, and visceral leishmaniasis. In this study, we have provided evidence that salivary gland extracts (SGE) of Lutzomyia longipalpis enhances L. amazonensis infection. BALB/c mice infected intradermally in the ear with 10(5) metacyclic promastigotes of L. amazonensis together with SGE (equivalent to 0.5 gland) showed an early onset of disease and larger lesions that contained approximately 3-log-units more parasites than did controls. To determine the potential mechanism underlying this enhancement, we assessed cytokine production via reverse transcriptase PCR and enzyme-linked immunosorbent assay. Mice coinjected with parasites and SGE displayed higher levels of interleukin-10 (IL-10) mRNA in the ear tissues, as well as higher levels of IL-10 in supernatants of restimulated draining lymph node (LN) cells, than did controls. Flow cytometric analysis revealed high frequencies of IL-10-producing CD4(+) and CD8(+) T cells in the draining LN of mice coinjected with the parasite and SGE. In addition, we examined bone marrow derived-macrophage cultures and detected increased IL-10 but decreased nitric oxide (NO) production in cells exposed to SGE prior to infection with L. amazonensis. Together, these results imply that the sand fly saliva facilitates Leishmania evasion of the host immune system by modulating IL-10 production.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977924      PMCID: PMC356033          DOI: 10.1128/IAI.72.3.1240-1247.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  62 in total

1.  The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-alpha and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor.

Authors:  M B Soares; R G Titus; C B Shoemaker; J R David; M Bozza
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

2.  Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production.

Authors:  A Eigler; B Siegmund; U Emmerich; K H Baumann; G Hartmann; S Endres
Journal:  J Leukoc Biol       Date:  1998-01       Impact factor: 4.962

3.  High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment.

Authors:  E Bourreau; G Prévot; J Gardon; R Pradinaud; P Launois
Journal:  J Infect Dis       Date:  2001-12-03       Impact factor: 5.226

4.  IL-10 mediates susceptibility to Leishmania donovani infection.

Authors:  M L Murphy; U Wille; E N Villegas; C A Hunter; J P Farrell
Journal:  Eur J Immunol       Date:  2001-10       Impact factor: 5.532

5.  Leishmania amazonensis-dendritic cell interactions in vitro and the priming of parasite-specific CD4(+) T cells in vivo.

Authors:  H Qi; V Popov; L Soong
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

Review 6.  Molecular aspects of parasite-vector and vector-host interactions in leishmaniasis.

Authors:  D Sacks; S Kamhawi
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

7.  Interleukin-10 and cAMP-elevating agents cooperate to induce suppressor of cytokine signaling-3 via a protein kinase A-independent signal.

Authors:  Sara Gasperini; Luca Crepaldi; Federica Calzetti; Luana Gatto; Chiara Berlato; Flavia Bazzoni; Akihiko Yoshimura; Marco A Cassatella
Journal:  Eur Cytokine Netw       Date:  2002 Jan-Mar       Impact factor: 2.737

8.  Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection.

Authors:  R V Morris; C B Shoemaker; J R David; G C Lanzaro; R G Titus
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

9.  Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection.

Authors:  Douglas E Jones; Mark R Ackermann; Ulrike Wille; Christopher A Hunter; Phillip Scott
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

10.  Phlebotomus papatasi saliva inhibits protein phosphatase activity and nitric oxide production by murine macrophages.

Authors:  J Waitumbi; A Warburg
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

View more
  52 in total

1.  Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis.

Authors:  Tatiana R de Moura; Fernanda O Novais; Fabiano Oliveira; Jorge Clarêncio; Almério Noronha; Aldina Barral; Claudia Brodskyn; Camila I de Oliveira
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Nucleosides present on phlebotomine saliva induce immunossuppression and promote the infection establishment.

Authors:  Vanessa Carregaro; José M Ribeiro; Jesus G Valenzuela; Djalma L Souza-Júnior; Diego L Costa; Carlo J F Oliveira; Laís A Sacramento; Manuela S L Nascimento; Cristiane M Milanezi; Fernando Q Cunha; João S Silva
Journal:  PLoS Negl Trop Dis       Date:  2015-04-07

3.  The protein LJM 111 from Lutzomyia longipalpis salivary gland extract (SGE) accounts for the SGE-inhibitory effects upon inflammatory parameters in experimental arthritis model.

Authors:  Renata Grespan; Henrique P Lemos; Vanessa Carregaro; Waldiceu A Verri; Fabricio O Souto; Carlo J F de Oliveira; Clarissa Teixeira; José Marcos Ribeiro; Jesus G Valenzuela; Fernando Q Cunha
Journal:  Int Immunopharmacol       Date:  2012-02-21       Impact factor: 4.932

4.  Maxadilan, the Lutzomyia longipalpis vasodilator, drives plasma leakage via PAC1-CXCR1/2-pathway.

Authors:  Erik Svensjö; Elvira M Saraiva; Rafael Silveira Amendola; Christina Barja-Fidalgo; Marcelo T Bozza; Ethan A Lerner; Mauro M Teixeira; Julio Scharfstein
Journal:  Microvasc Res       Date:  2011-10-19       Impact factor: 3.514

5.  Anopheles gambiae Lacking AgTRIO Inefficiently Transmits Plasmodium berghei to Mice.

Authors:  Yu-Min Chuang; Marianna Freudzon; Jing Yang; Yuemei Dong; George Dimopoulos; Erol Fikrig
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

6.  CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection.

Authors:  Jiaxiang Ji; Joseph Masterson; Jiaren Sun; Lynn Soong
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

Review 7.  Sand flies, Leishmania, and transcriptome-borne solutions.

Authors:  Fabiano Oliveira; Ryan C Jochim; Jesus G Valenzuela; Shaden Kamhawi
Journal:  Parasitol Int       Date:  2008-08-16       Impact factor: 2.230

8.  Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine.

Authors:  Rafael D Mesquita; Alan Brito Carneiro; André Bafica; Felipe Gazos-Lopes; Christina M Takiya; Thaís Souto-Padron; Danielle P Vieira; Antônio Ferreira-Pereira; Igor C Almeida; Rodrigo T Figueiredo; Bárbara N Porto; Marcelo T Bozza; Aurélio V Graça-Souza; Angela H C S Lopes; Geórgia C Atella; Mário A C Silva-Neto
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

9.  Lutzomyia longipalpis salivary peptide maxadilan alters murine dendritic cell expression of CD80/86, CCR7, and cytokine secretion and reprograms dendritic cell-mediated cytokine release from cultures containing allogeneic T cells.

Authors:  William H Wheat; Kristen E Pauken; Robin V Morris; Richard G Titus
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

10.  Proteophosophoglycans regurgitated by Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival.

Authors:  Matthew Rogers; Pascale Kropf; Beak-San Choi; Rod Dillon; Maria Podinovskaia; Paul Bates; Ingrid Müller
Journal:  PLoS Pathog       Date:  2009-08-21       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.